Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Yuanfeng Gong

Matched on ORCID iD 0000-0001-7742-6286; OpenAlex author ID A5005757913. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: 4 papers

Papers 9

  1. Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2021/6682697↗
  2. Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. Co-author DOI 10.1155/2021/9949272↗
  3. Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy. Co-author DOI 10.1177/11795549211024149↗
  4. CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer. Co-author DOI 10.7150/jca.57082↗
  5. B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8+ T cells in pancreatic cancer. Co-author DOI 10.18632/aging.202255↗
  6. Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis. Co-author DOI 10.3390/nu9040394↗
  7. Optimized construction of MUC1-VNTRn DNA vaccine and its anti-pancreatic cancer efficacy. Co-author DOI 10.3892/ol.2017.5717↗
  8. Cholelithiasis and risk of pancreatic cancer: systematic review and meta-analysis of 21 observational studies. Co-author DOI 10.1007/s10552-014-0458-3↗
  9. Gastrectomy and risk of pancreatic cancer: systematic review and meta-analysis of observational studies. Co-author DOI 10.1007/s10552-012-0005-z↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chuanzhao Zhang · 5 shared papers, 2020–2021 · strength 0.60
  2. Hongkai Zhuang · 5 shared papers, 2020–2021 · strength 0.60
  3. Shanzhou Huang · 5 shared papers, 2020–2021 · strength 0.60
  4. Zuyi Ma · 5 shared papers, 2020–2021 · strength 0.60
  5. Zixuan Zhou · 5 shared papers, 2020–2021 · strength 0.60
  6. Baohua Hou · 5 shared papers, 2020–2021 · strength 0.60
  7. Zhenchong Li · 4 shared papers, 2021 · strength 0.48
  8. Yiping Zou · 2 shared papers, 2021 · strength 0.23
  9. Bowen Huang · 2 shared papers, 2021 · strength 0.23
  10. Shujie Wang · 1 shared paper, 2021 · strength 0.12
  11. Bo Chen · 1 shared paper, 2021 · strength 0.12
  12. Quanbo Zhou · 2 shared papers, 2012–2017 · strength 0.11
  13. Rufu Chen · 2 shared papers, 2012–2017 · strength 0.11
  14. Qi Zhou · 1 shared paper, 2021 · strength 0.11
  15. Hui Tang · 1 shared paper, 2017 · strength 0.08
  16. Hui Tang · 1 shared paper, 2014 · strength 0.05
  17. Zhihua Li · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.